Open AccessBudesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]
Author(s) -
Shih-Lung Cheng,
Ming-Lin Ho,
Yun-Fa Lai,
Hao-Chien Wang,
Jeng-Yuan Hsu,
Shih-Feng Liu,
Ming-Shyan Huang,
Cheng-Hung Lee,
ChingHsiung Lin,
LiangWen Hang,
Yu-Chih Liu,
Kuang-Yao Yang,
Jia-Horng Wang
Publication year - 2021
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
ISSN - 1177-8881
DOI - 10.2147/dddt.s300704
Subject(s) - formoterol , salmeterol , budesonide , fluticasone propionate , medicine , fluticasone , asthma , formoterol fumarate , pharmacology , anesthesia